A single arm phase II study of single agent pemetrexed in platinum resistant/ refractory epithelial ovarian or primary peritoneal cancer

被引：0
|
作者：
Parampalli, S. [1 ]
Khurana, S. [1 ]
Kumar, A. [1 ]
Malik, P. [1 ]
Pramanik, R. [2 ]
Mathur, S. [3 ]
Kumar, M. [4 ]
Bhatla, N. [5 ]
Ray, M. [6 ]
机构：
[1] AIIMS All India Inst Med Sci, Med Oncol, New Delhi, India
[2] Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi, India
[3] AIIMS All India Inst Med Sci, Pathol, New Delhi, India
[4] AIIMS All India Inst Med Sci, Radiodiag, New Delhi, India
[5] AIIMS All India Inst Med Sci, Gynecol Oncol, New Delhi, India
[6] AIIMS All India Inst Med Sci, Surg Oncol, New Delhi, India
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.741
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
327TiP
引用
收藏
页码：S1598 / S1598
页数：1
相关论文
共 50 条
  • [1] A single arm phase II study of single agent Pemetrexed in platinum resistant/refractory epithelial ovarian or primary peritoneal cancer
    Upadhya, S.
    Khurana, S.
    Kumar, A.
    Malik, P. S.
    Pramanik, R.
    Kataria, B.
    Mathur, S.
    Kumar, M.
    Bhatla, N.
    Ray, M.
    ANNALS OF ONCOLOGY, 2024, 35
  • [2] Anlotinib in patients with recurrent platinum resistant/refractory ovarian cancer: a prospective, single arm, phase II study
    Shen, Wenbin
    Jing, Chuyu
    Tian, Wenjuan
    Zhang, Wei
    Ren, Yulan
    Shan, Boer
    Wang, Huaying
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (11) : 1764 - 1770
  • [3] Phase II study of anlotinib plus pemetrexed for platinum-resistant epithelial ovarian cancer
    Chen, J.
    Wei, W.
    Zheng, L.
    Li, H.
    Feng, Y.
    Wan, T.
    Qiu, J.
    Jiang, X.
    Xiong, Y.
    Li, J.
    Huang, H.
    Song, L.
    Liu, J.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S630 - S631
  • [4] A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer
    Vergote, Ignace
    Calvert, Hilary
    Kania, Marek
    Kaiser, Christopher
    Zimmermann, Annamaria Hayden
    Sehouli, Jalid
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (08) : 1415 - 1423
  • [5] Anlotinib plus pemetrexed in patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study
    Chen, J.
    Wei, W.
    Zheng, L.
    Li, H.
    Feng, Y.
    Wan, T.
    Huang, Q.
    Liu, G.
    Tu, H.
    Qiu, J.
    Jiang, X.
    Xiong, Y.
    Zheng, M.
    Li, J.
    Huang, H.
    Song, L.
    Liu, J.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S734 - S734
  • [6] A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
    Bell-McGuinn, Katherine M.
    Matthews, Carolyn M.
    Ho, Steffan N.
    Barve, Minal
    Gilbert, Lucy
    Penson, Richard T.
    Lengyel, Ernst
    Palaparthy, Rameshraja
    Gilder, Kye
    Vassos, Artemios
    McAuliffe, William
    Weymer, Sara
    Barton, Jeremy
    Schilder, Russell J.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (02) : 273 - 279
  • [7] Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study
    Zhou, Huimei
    Liu, Qian
    Zhang, Depu
    Li, Qingshui
    Cao, Dongyan
    Cheng, Ninghai
    Wan, Xirun
    Zhang, Ying
    Feng, Fengzhi
    Xiang, Yang
    Yang, Jiaxin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (11) : 1761 - 1767
  • [8] A phase II study of single agent gemcitabine in recurrent epithelial ovarian cancer
    Tay, SK
    Tan, PK
    Wong, L
    Wong, CB
    7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, : 317 - 321
  • [9] Anlotinib combined with pemetrexed as a further treatment of patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study
    Gaillard, Stephanie
    Duska, Linda
    Broadwater, Gloria
    McNally, Leah
    Lee, Paula
    Davidson, Brittany
    Previs, Rebecca
    Moss, Haley
    Berchuck, Andrew
    Nixon, Andrew
    Yi, John
    Bookman, Michael
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S61 - S62
  • [10] A phase II study evaluating the safety and efficacy of patupilone in patients with platinum refractory/resistant ovarian, primary fallopian, or peritoneal cancer
    Smit, W. M.
    Sufliarsky, J.
    Werner, T. L.
    Dizon, D.
    Wagnerova, M.
    Hirte, H. W.
    Delaney, R.
    Li, J.
    Weber, D.
    Schellens, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345